BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8217836)

  • 1. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
    Facon T; Lai JL; Nataf E; Preudhomme C; Zandecki M; Hammad M; Wattel E; Jouet JP; Bauters F
    Br J Haematol; 1993 Aug; 84(4):743-5. PubMed ID: 8217836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
    Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
    Smadja NV; Louvet C; Isnard F; Dutel JL; Grange MJ; Varette C; Krulik M
    Br J Haematol; 1995 Jul; 90(3):619-24. PubMed ID: 7647003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
    Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells.
    Brantschen S; Gauchat JF; De Weck AL; Stadler BM
    Eur J Immunol; 1989 Nov; 19(11):2017-23. PubMed ID: 2480900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
    Kovacs CJ; Evans MJ; Daly BM; Thomas-Patterson D; Johnke RM; Powell DS
    J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    Millar BC; Bell JB; Montes A; Millar JL; Maitland JA; Treleaven J; Viner C; Gore M; McElwain TJ
    Br J Haematol; 1990 Jul; 75(3):366-72. PubMed ID: 2201402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
    Li JT; Chang NB; Liu H; Pei L
    Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1039-42. PubMed ID: 22333174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
    Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
    Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.
    Han ZC; Bellucci S; Wan HY; Caen JP
    Br J Haematol; 1992 May; 81(1):1-5. PubMed ID: 1520606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
    Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
    Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
    Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
    Hernández JM; Gutiérrez NC; Almeida J; García JL; Sánchez MA; Mateo G; Ríos A; San Miguel JF
    Br J Haematol; 1998 Oct; 103(1):163-7. PubMed ID: 9792304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.